{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T08:09:01Z","timestamp":1772870941634,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.mehy.2011.08.035","type":"journal-article","created":{"date-parts":[[2011,9,15]],"date-time":"2011-09-15T07:11:28Z","timestamp":1316070688000},"page":"1006-1008","source":"Crossref","is-referenced-by-count":16,"title":["Tapering antidepressants: Is 3 months slow enough?"],"prefix":"10.1016","volume":"77","author":[{"given":"James","family":"Phelps","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2011.08.035_b0005","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/archgenpsychiatry.2009.81","article-title":"National patterns in antidepressant medication treatment","volume":"66","author":"Olfson","year":"2009","journal-title":"Arch Gen Psychiatry"},{"issue":"suppl 4","key":"10.1016\/j.mehy.2011.08.035_b0010","first-page":"27","article-title":"Antidepressant discontinuation syndrome: consensus panel recommendations for clinical management and additional research","volume":"67","author":"Schatzberg","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.mehy.2011.08.035_b0015","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1017\/S1461145706007462","article-title":"Effects of gradual discontinuation of selective serotonin reuptake inhibitors in panic disorder with agoraphobia","volume":"10","author":"Fava","year":"2007","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.mehy.2011.08.035_b0020","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4088\/PCC.v03n0404","article-title":"Steps following attainment of remission: discontinuation of antidepressant therapy","volume":"3","author":"Shelton","year":"2001","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.mehy.2011.08.035_b0025","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/0269881107081550","article-title":"The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study","volume":"22","author":"Tint","year":"2008","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.mehy.2011.08.035_b0030","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1176\/appi.ajp.2010.09060880","article-title":"Illness risk following rapid versus gradual discontinuation of antidepressants","volume":"167","author":"Baldessarini","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.mehy.2011.08.035_b0035","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(07)60237-2","article-title":"Narcolepsy with cataplexy","volume":"369","author":"Dauvilliers","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2011.08.035_b0040","first-page":"557","article-title":"Narcolepsy: current treatment options and future approaches","volume":"4","author":"Billiard","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.mehy.2011.08.035_b0045","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s10072-007-0849-2","article-title":"Status cataplecticus misdiagnosed as recurrent syncope","volume":"28","author":"Calabr\u00f2","year":"2007","journal-title":"Neurol Sci"},{"key":"10.1016\/j.mehy.2011.08.035_b0050","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.sleep.2008.04.004","article-title":"Exacerbation of cataplexy following gradual withdrawal of antidepressants: Manifestation of probable protracted rebound cataplexy","volume":"10","author":"Ristanovic","year":"2009","journal-title":"Sleep Med"},{"key":"10.1016\/j.mehy.2011.08.035_b0055","doi-asserted-by":"crossref","unstructured":"Xyrem International Study Group. Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients. Sleep Med 2005;6:415-21.","DOI":"10.1016\/j.sleep.2005.03.010"},{"key":"10.1016\/j.mehy.2011.08.035_b0060","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0006-3223(03)00528-6","article-title":"Neurobiology of antidepressant withdrawal: implications for the longitudinal outcome of depression","volume":"54","author":"Harvey","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mehy.2011.08.035_b0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0301-0511(01)00090-4","article-title":"Sleep and depression\u2013results from psychobiological studies: an overview","volume":"57","author":"Riemann","year":"2001","journal-title":"Biol Psychol"},{"key":"10.1016\/j.mehy.2011.08.035_b0070","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4088\/JCP.08m04909gre","article-title":"Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety","volume":"71","author":"Ghaemi","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.mehy.2011.08.035_b0075","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/archpsyc.1993.01820180046005","article-title":"Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders","volume":"50","author":"Faedda","year":"1993","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.mehy.2011.08.035_b0080","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4088\/JCP.v57n1001","article-title":"Effects of the rate of discontinuing lithium maintenance treatment in bipolar disorders","volume":"57","author":"Baldessarini","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.mehy.2011.08.035_b0085","unstructured":"Associated Press. Stuck on meds: Some can\u2019t quit antidepressants. MSNBC, August 31, 2006 (available at http:\/\/www.msnbc.msn.com\/id\/14126142\/ns\/health-mental_health, accessed 11.16.10)."},{"key":"10.1016\/j.mehy.2011.08.035_b0090","doi-asserted-by":"crossref","first-page":"333","DOI":"10.31887\/DCNS.2009.11.3\/jhunsberger","article-title":"The neurotrophic and neuroprotective effects of psychotropic agents","volume":"11","author":"Hunsberger","year":"2009","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.mehy.2011.08.035_b0095","unstructured":"Fava GA, Offidani E. The mechanisms of tolerance in antidepressant action. Prog Neuropsychopharmacol Biol Psychiatry 2010 Aug 20. [Epub ahead of print]."}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987711004270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987711004270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T20:26:59Z","timestamp":1638649619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987711004270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0306987711004270"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2011.08.035","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}